Cargando…

Hematologic complications with age in Shwachman-Diamond syndrome

Shwachman-Diamond syndrome (SDS) is an inherited bone marrow failure syndrome with leukemia predisposition. An understanding of the hematologic complications of SDS with age could guide clinical management, but data are limited for this rare disease. We conducted a cohort study of 153 subjects from...

Descripción completa

Detalles Bibliográficos
Autores principales: Furutani, Elissa, Liu, Shanshan, Galvin, Ashley, Steltz, Sarah, Malsch, Maggie M., Loveless, Sara K., Mount, Leann, Larson, Jordan H., Queenan, Kelan, Bertuch, Alison A., Fleming, Mark D., Gansner, John M., Geddis, Amy E., Hanna, Rabi, Keel, Sioban B., Lau, Bonnie W., Lipton, Jeffrey M., Lorsbach, Robert, Nakano, Taizo A., Vlachos, Adrianna, Wang, Winfred C., Davies, Stella M., Weller, Edie, Myers, Kasiani C., Shimamura, Akiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753194/
https://www.ncbi.nlm.nih.gov/pubmed/34758064
http://dx.doi.org/10.1182/bloodadvances.2021005539
Descripción
Sumario:Shwachman-Diamond syndrome (SDS) is an inherited bone marrow failure syndrome with leukemia predisposition. An understanding of the hematologic complications of SDS with age could guide clinical management, but data are limited for this rare disease. We conducted a cohort study of 153 subjects from 143 families with confirmed biallelic SBDS mutations enrolled on the North American Shwachman Diamond Registry or Bone Marrow Failure Registry. The SBDS c.258 + 2T>C variant was present in all but 1 patient. To evaluate the association between blood counts and age, 2146 blood counts were analyzed for 119 subjects. Absolute neutrophil counts were positively associated with age (P < .0001). Hemoglobin was also positively associated with age up to 18 years (P < .0001), but the association was negative thereafter (P = .0079). Platelet counts and marrow cellularity were negatively associated with age (P < .0001). Marrow cellularity did not correlate with blood counts. Severe marrow failure necessitating transplant developed in 8 subjects at a median age of 1.7 years (range, 0.4-39.5), with 7 of 8 requiring transplant prior to age 8 years. Twenty-six subjects (17%) developed a myeloid malignancy (16 myelodysplasia and 10 acute myeloid leukemia) at a median age of 12.3 years (range, 0.5-45.0) and 28.4 years (range, 14.4-47.3), respectively. A lymphoid malignancy developed in 1 patient at the age of 16.9 years. Hematologic complications were the major cause of mortality (17/20 deaths; 85%). These data inform surveillance of hematologic complications in SDS.